TY - JOUR KW - Analgesics, Opioid/administration & dosage/adverse effects/therapeutic use KW - Benzodiazepines KW - Benzodiazepines/administration & dosage/adverse effects/therapeutic use KW - Chronic Pain KW - Chronic Pain/drug therapy KW - Drug overdose KW - Drug Therapy, Combination KW - Humans KW - Mortality KW - Opioid analgesics KW - Opioid-Related Disorders/etiology/prevention & control KW - Practice Patterns, Physicians' KW - Risk KW - therapeutic use AU - L. R. Webster AU - G. M. Reisfield AU - N. Dasgupta A1 - AB - The provision of long-term opioid analgesic therapy for chronic pain requires a careful risk/benefit analysis followed by clinical safety measures to identify and reduce misuse, abuse, and addiction and their associated morbidity and mortality. Multiple data sources show that benzodiazepines, prescribed for comorbid insomnia, anxiety, and mood disorders, heighten the risk of respiratory depression and other adverse outcomes when combined with opioid therapy. Evidence is presented for hazards associated with coadministration of opioids and benzodiazepines and the need for caution when initiating opioid therapy for chronic pain. Clinical recommendations follow, as drawn from 2 previously published literature reviews, one of which proffers 8 principles for safer opioid prescribing; the other review presents risks associated with benzodiazepines, suggests alternatives for co-prescribing benzodiazepines and opioids, and outlines recommendations regarding co-prescribing if alternative therapies are ineffective. BT - Postgraduate medicine C5 - Opioids & Substance Use; Education & Workforce CP - 1 CY - England IS - 1 JF - Postgraduate medicine N2 - The provision of long-term opioid analgesic therapy for chronic pain requires a careful risk/benefit analysis followed by clinical safety measures to identify and reduce misuse, abuse, and addiction and their associated morbidity and mortality. Multiple data sources show that benzodiazepines, prescribed for comorbid insomnia, anxiety, and mood disorders, heighten the risk of respiratory depression and other adverse outcomes when combined with opioid therapy. Evidence is presented for hazards associated with coadministration of opioids and benzodiazepines and the need for caution when initiating opioid therapy for chronic pain. Clinical recommendations follow, as drawn from 2 previously published literature reviews, one of which proffers 8 principles for safer opioid prescribing; the other review presents risks associated with benzodiazepines, suggests alternatives for co-prescribing benzodiazepines and opioids, and outlines recommendations regarding co-prescribing if alternative therapies are ineffective. PP - England PY - 2015 SN - 1941-9260; 0032-5481 SP - 27 EP - 32 EP - T1 - Eight principles for safer opioid prescribing and cautions with benzodiazepines T2 - Postgraduate medicine TI - Eight principles for safer opioid prescribing and cautions with benzodiazepines U1 - Opioids & Substance Use; Education & Workforce U2 - 25526233 VL - 127 VO - 1941-9260; 0032-5481 Y1 - 2015 ER -